
Washington Post reporter and panel moderator Lauren Weber, talks to JAMA Editor in Chief Kirsten Bibbins-Domingo and co-moderator, Kaiser Family Foundation Senior Fellow Irving Washington, during the “Malignant misinformation: The quest for a ‘cure'” roundtable discussion and awards luncheon at HJ23 in St. Louis. The second panelist, Garth Graham, M.D., global head of health care and public health at Google/YouTube, is not pictured, but participated via Zoom. (Photo by Zachary Linhares)
Scientific knowledge is no match for entrenched misinformation, JAMA Editor in Chief Kirsten Bibbins-Domingo, M.D., told a luncheon crowd at Health Journalism 2023 on Saturday, March 11 in St. Louis. Just look at ivermectin.
JAMA recently published the fourth big, randomized trial to find that the antiparasitic medication doesn’t improve COVID symptoms. Yet Bibbins-Domingo said she is aware that no amount of high-quality evidence will quash persistent claims that ivermectin is a COVID miracle cure. At the same time, she said, ethical questions arise when researchers continue to study what many consider to be settled science.